Correction: Bourefis et al. HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA. Cancers 2022, 14, 4773

Key Points

• To correct previous findings regarding the prognostic value of HSP27 and menin in prostate cancer.
• Data correction in the published study on biomarkers.
• Re-evaluation of HSP27 and menin expression levels in prostate cancer samples.
• Assessment of biomarkers' relationship with prostate cancer aggressiveness and PSA levels.
• HSP27 is confirmed as a prognostic biomarker in prostate cancer.
• Menin's role is clarified in the context of prostate cancer aggressiveness.
• The independence of HSP27 and PSA levels reaffirms their significance as biomarkers.

Abstract